To facilitate interpretation of complex tumor sequencing data and clinical trial genomic
eligibility criteria, we developed MatchMiner, an open-source platform to computationally
match cancer patients to precision medicine clinical trials based on clinical and
genomic features. MatchMiner enables physicians to identify clinical trial options
for individual patients and enables clinical trial investigators to identify patients
eligible for genomically-driven trials. MatchMiner can also be used to display profiling
reports, independent of trial matching.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of CancerAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2020 Elsevier B.V. Published by Elsevier Inc. All rights reserved.
